Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Tosedostat

EU orphan designation number: EU/3/09/659   
Active ingredient: Tosedostat
Indication: Treatment of acute myeloid leukaemia
Sponsor: Voisin Consulting S.A.R.L.
3 rue des Longs Prés, F-92100 Boulogne-Billancourt, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/07/2009 Orphan designation EMEA/OD/028/09 (2009)6033 of 24/07/2009
26/03/2015 Change of name and/or address of sponsor
13/05/2015 Transfer of orphan designation EMA/OD/028/09/T/01 (2015)3243 of 07/05/2015